NCOR1 and bladder transitional cell carcinoma: In the TCGA-BLCA cohort, patients with NCOR1-WT had a worse OS compared with NCOR1-DEL patients (P = 0.032, HR = 4.08; 95CI: 2–8.35; Figure S2B).